Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.00
+0.06 (0.86%)
At close: Mar 9, 2026, 4:00 PM EDT
6.86
-0.14 (-2.00%)
After-hours: Mar 9, 2026, 7:16 PM EDT
Kezar Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 51 | 49 | 69 | 481 | 822 | 242 | |
| Market Cap Growth | 16.13% | -28.81% | -85.69% | -41.42% | 240.23% | 214.65% | |
| Enterprise Value | -29 | -82 | -130 | 204 | 706 | 97 | |
| Last Close Price | 6.94 | 6.72 | 9.47 | 70.40 | 167.20 | 52.20 | |
| PS Ratio | - | - | 9.84 | - | - | - | |
| PB Ratio | 0.61 | 0.42 | 0.37 | 1.78 | 4.17 | 1.71 | |
| P/TBV Ratio | 0.62 | 0.42 | 0.37 | 1.78 | 4.17 | 1.71 | |
| Debt / Equity Ratio | 0.12 | 0.14 | 0.10 | 0.08 | 0.07 | 0.04 | |
| Net Debt / Equity Ratio | -0.97 | -0.99 | -0.97 | -0.95 | -0.99 | -0.96 | |
| Net Debt / EBITDA Ratio | 1.25 | 1.32 | 1.75 | 3.64 | 3.66 | 3.26 | |
| Net Debt / FCF Ratio | 1.42 | 1.56 | 2.19 | 4.22 | 4.55 | 3.63 | |
| Asset Turnover | - | - | 0.03 | - | - | - | |
| Quick Ratio | 6.89 | 6.53 | 11.48 | 25.22 | 25.37 | 21.92 | |
| Current Ratio | 7.07 | 6.76 | 11.66 | 25.98 | 25.77 | 22.48 | |
| Return on Equity (ROE) | -56.86% | -55.00% | -44.54% | -29.24% | -32.34% | -38.12% | |
| Return on Assets (ROA) | -31.27% | -30.45% | -25.26% | -17.19% | -18.48% | -22.24% | |
| Return on Capital Employed (ROCE) | -77.70% | -71.70% | -51.70% | -24.70% | -26.10% | -29.50% | |
| Earnings Yield | -120.37% | -170.78% | -147.92% | -14.18% | -6.65% | -17.28% | |
| FCF Yield | -110.53% | -151.42% | -121.18% | -12.55% | -5.20% | -15.38% | |
| Buyback Yield / Dilution | -0.36% | -0.48% | -7.70% | -27.69% | -19.90% | -130.58% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.